Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

FFR and IFR: Are We Talking About the Same Thing?

To evaluate borderline coronary lesions (a 40% to 70% obstruction), determining associated ischemia is paramount. For this purpose, pressure gradients are measured across the stenosis. These measurements can be hyperemic, such as the fractional flow reserve (FFR), or taken at rest, such as the instantaneous wave-free ratio (iFR).

FFR e IFR ¿Hablamos de lo mismo?

According to the iFR-SWEDEHEART 5-year follow-up outcomes, both strategies have demonstrated effectiveness, as iFR is non-inferior to FFR. However, in different reports, these measurements have shown a correlation close to 80%. An altered reactivity of endothelial cells to vasoactive drugs might explain the observed discordance.

Whether this endothelial phenomenon can be caused by genetic polymorphisms of enzymes responsible for vasodilatation, such as endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (HO-1), is uncertain.

Building on this, the aim of this study was to analyze lesions and patients with discordant FFR and iFR measurements, and to determine whether polymorphism in the eNOS gene and in HO-1 influence coronary pressure and flow measurements.

Enrollment included patients with acute coronary syndrome (non-culprit vessel measurement) and chronic coronary syndromes in centers in the Czech Republic, Japan, and Argentina. FFR, IFR, and—in some cases—coronary flow reserve (CFR) were measured. Nitroglycerin 200 µg pre-measurement and adenosine 240 µg were systematically administered for pressure and flow measurements.

Read also: TAVR, More Information Supports Its Use.

Three groups of tests were classified according to positive or negative results: FFR/iFR concordance, FFRp/iFRn discordance, and FFRn/iFRp discordance.

A total of 1884 measurements from 1564 patients were analyzed; most measurements corresponded to the anterior descending artery (58%). FFR/iFR discordance was observed in 20.9% of the measurements, with FFRp/iFRn being the most frequent. In flow measurements, CFR correlated better with iFR (R = 0.56; p < 0.0001) than with FFR (R = 0.36; p <0.0001). When genetic analysis was conducted, eNOS and HO-1 polymorphisms showed no changes in FFR or IFR values.

Right coronary lesions presented a higher FFRp/iFRn index, which would indicate a distinctive coronary flow (absence of maximum flow in meso-diastole). In turn, this FFRp/iFRn discordance was observed in situations with indemnity of endothelial function, especially in young patients, and more frequently in men than in women.

Read also: Using Biolimus-Coated Balloons for Treating Small-Vessel Disease Yields Promising Results.

The FFRn/iFRp discordance presented increased microvascular resistance (decreased CFR). These were generally older patients who suffered more frequently from chronic kidney disease. This discordance was more commonly observed in patients with eNOS and HO-1 polymorphism.

Conclusions

There was a 21% discordance between FFR and iFR measurements. FFRn/iFRp discordance is probably caused by a defective endothelial reaction to vasodilator drugs. Additionally, eNOS and HO-1 gene polymorphisms were more frequently observed in this group.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study.

Reference: Kovarnik, Tomas et al. “Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study.” Journal of the American Heart Association vol. 11,9 (2022): e021490. doi:10.1161/JAHA.121.021490.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...